309 related articles for article (PubMed ID: 36247151)
21. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.
Tsai MM; Wang CS; Tsai CY; Huang HW; Chi HC; Lin YH; Lu PH; Lin KH
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322246
[TBL] [Abstract][Full Text] [Related]
22. Circulating exosomal small RNAs are promising non-invasive diagnostic biomarkers for gastric cancer.
Ge L; Zhang N; Li D; Wu Y; Wang H; Wang J
J Cell Mol Med; 2020 Dec; 24(24):14502-14513. PubMed ID: 33169519
[TBL] [Abstract][Full Text] [Related]
23. Review of recent efforts to discover biomarkers for early detection, monitoring, prognosis, and prediction of treatment responses of patients with gastric cancer.
Sawaki K; Kanda M; Kodera Y
Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):657-670. PubMed ID: 29902383
[TBL] [Abstract][Full Text] [Related]
24. Cell-Free DNA Variant Sequencing Using Plasma and AR-V7 Testing of Circulating Tumor Cells in Prostate Cancer Patients.
Lieb V; Abdulrahman A; Weigelt K; Hauch S; Gombert M; Guzman J; Bellut L; Goebell PJ; Stöhr R; Hartmann A; Wullich B; Taubert H; Wach S
Cells; 2021 Nov; 10(11):. PubMed ID: 34831445
[TBL] [Abstract][Full Text] [Related]
25. MicroRNAs as potential biomarkers for diagnosis, therapy and prognosis of gastric cancer.
Yuan HL; Wang T; Zhang KH
Onco Targets Ther; 2018; 11():3891-3900. PubMed ID: 30013369
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer.
Jin C; Shi W; Wang F; Shen X; Qi J; Cong H; Yuan J; Shi L; Zhu B; Luo X; Zhang Y; Ju S
Oncotarget; 2016 Aug; 7(32):51763-51772. PubMed ID: 27322075
[TBL] [Abstract][Full Text] [Related]
27. Exosomal Functional Cargoes from Liquid Biopsy of Gastric Cancer: A Systematic Review of Studies With Potential Clinical Relevance.
Virgilio E; Montali F; Annicchiarico A; Salvemini C; Baldinu M; Giarnieri E; Montagnini M; Villani S; Proietti A; D'Urso R; Costi R
Anticancer Res; 2022 May; 42(5):2249-2259. PubMed ID: 35489719
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNAs in gastric cancer: versatile mechanisms and potential for clinical translation.
Zhao J; Liu Y; Huang G; Cui P; Zhang W; Zhang Y
Am J Cancer Res; 2015; 5(3):907-27. PubMed ID: 26045977
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide long non-coding RNAs identified a panel of novel plasma biomarkers for gastric cancer diagnosis.
Zheng R; Liang J; Lu J; Li S; Zhang G; Wang X; Liu M; Wang W; Chu H; Tao G; Zhao Q; Wang M; Du M; Qiang F; Zhang Z
Gastric Cancer; 2019 Jul; 22(4):731-741. PubMed ID: 30603909
[TBL] [Abstract][Full Text] [Related]
30. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
Chen C; Tang X; Liu Y; Zhu J; Liu J
Int J Oncol; 2019 May; 54(5):1511-1524. PubMed ID: 30896792
[TBL] [Abstract][Full Text] [Related]
31. Emerging Role of Circulating Tumor Cells in Gastric Cancer.
Thanh Huong P; Gurshaney S; Thanh Binh N; Gia Pham A; Hoang Nguyen H; Thanh Nguyen X; Pham-The H; Tran PT; Truong Vu K; Xuan Duong N; Pelucchi C; La Vecchia C; Boffetta P; Nguyen HD; Luu HN
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32183503
[TBL] [Abstract][Full Text] [Related]
32. Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer.
Jiang N; Pan J; Fang S; Zhou C; Han Y; Chen J; Meng X; Jin X; Gong Z
Clin Chim Acta; 2019 Aug; 495():331-337. PubMed ID: 31054913
[TBL] [Abstract][Full Text] [Related]
33. Emerging blood-based biomarkers for detection of gastric cancer.
Kalniņa Z; Meistere I; Kikuste I; Tolmanis I; Zayakin P; Linē A
World J Gastroenterol; 2015 Nov; 21(41):11636-53. PubMed ID: 26556992
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in the molecular diagnostics of gastric cancer.
Kanda M; Kodera Y
World J Gastroenterol; 2015 Sep; 21(34):9838-52. PubMed ID: 26379391
[TBL] [Abstract][Full Text] [Related]
35. The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.
Bracht JWP; Mayo-de-Las-Casas C; Berenguer J; Karachaliou N; Rosell R
Curr Oncol Rep; 2018 Jul; 20(9):70. PubMed ID: 30030656
[TBL] [Abstract][Full Text] [Related]
36. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of circulating tumor cells in gastric cancer patients.
Zhou J; Ma X; Bi F; Liu M
Oncotarget; 2017 Apr; 8(15):25713-25720. PubMed ID: 28147337
[TBL] [Abstract][Full Text] [Related]
38. Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer.
Raza A; Khan AQ; Inchakalody VP; Mestiri S; Yoosuf ZSKM; Bedhiafi T; El-Ella DMA; Taib N; Hydrose S; Akbar S; Fernandes Q; Al-Zaidan L; Krishnankutty R; Merhi M; Uddin S; Dermime S
J Exp Clin Cancer Res; 2022 Mar; 41(1):99. PubMed ID: 35292091
[TBL] [Abstract][Full Text] [Related]
39. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
[TBL] [Abstract][Full Text] [Related]
40. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
Moldogazieva NT; Zavadskiy SP; Terentiev AA
Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]